Item Type | Name |
Academic Article
|
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.
|
Academic Article
|
Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.
|
Academic Article
|
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.
|
Academic Article
|
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.
|
Academic Article
|
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.
|
Academic Article
|
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.
|
Academic Article
|
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus.
|
Academic Article
|
Rituximab: wanted dead or alive...
|
Academic Article
|
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
|
Academic Article
|
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
|
Academic Article
|
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
|
Academic Article
|
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.
|
Academic Article
|
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
|
Academic Article
|
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
|
Academic Article
|
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.
|
Academic Article
|
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
|
Academic Article
|
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
|
Academic Article
|
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.
|
Academic Article
|
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus.
|
Academic Article
|
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.
|
Academic Article
|
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry.
|
Academic Article
|
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
|
Academic Article
|
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
|
Academic Article
|
Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK.
|
Academic Article
|
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.
|
Academic Article
|
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.
|
Academic Article
|
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.
|
Academic Article
|
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
|
Academic Article
|
A 2014 update on the management of patients with systemic lupus erythematosus.
|
Academic Article
|
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
|
Academic Article
|
Which antiphospholipid antibody tests are most useful?
|
Academic Article
|
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
|
Academic Article
|
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.
|
Academic Article
|
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.
|
Academic Article
|
A polymorphism within IL21R confers risk for systemic lupus erythematosus.
|
Academic Article
|
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus.
|
Academic Article
|
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
|
Academic Article
|
Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus.
|
Academic Article
|
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
|
Academic Article
|
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
|
Academic Article
|
Disease-specific patient reported outcome tools for systemic lupus erythematosus.
|
Academic Article
|
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.
|
Academic Article
|
Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries.
|
Academic Article
|
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
|
Academic Article
|
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
|
Academic Article
|
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes.
|
Academic Article
|
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
|
Academic Article
|
Novel evidence-based systemic lupus erythematosus responder index.
|
Academic Article
|
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.
|
Academic Article
|
The genetics of systemic lupus erythematosus and implications for targeted therapy.
|
Academic Article
|
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus.
|
Academic Article
|
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21.
|
Academic Article
|
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.
|
Academic Article
|
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon a monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
|
Academic Article
|
Evaluation of TRAF6 in a large multiancestral lupus cohort.
|
Academic Article
|
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
|
Academic Article
|
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
|
Academic Article
|
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
|
Academic Article
|
Sifalimumab, an anti-interferon-a monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
|
Academic Article
|
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.
|
Academic Article
|
Selection of a gene for apolipoprotein A1 using autoantibodies from a patient with systemic lupus erythematosus.
|
Academic Article
|
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
|
Academic Article
|
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
|
Academic Article
|
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
|
Academic Article
|
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
|
Academic Article
|
Biological impact of iberdomide in patients with active systemic lupus erythematosus.
|
Academic Article
|
Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature.
|